We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
Cap. Flow
+$324M
Cap. Flow %
2.32%
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391

Top Buys

Rank Stock Value
1
MUB icon
iShares National Muni Bond ETF
MUB
+$176M
2
INFY icon
Infosys
INFY
+$102M
3
K
Kellanova
K
+$74.6M
4
AMZN icon
Amazon
AMZN
+$58.6M
5
BABA icon
Alibaba
BABA
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 10.38%
2 Financials 4.13%
3 Consumer Discretionary 2.33%
4 Communication Services 2.26%
5 Healthcare 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COHR icon
1376
Coherent
COHR
$55.2B
-60,000
Closed -$3.9M
COR icon
1377
Cencora
COR
$60.3B
-12,583
Closed -$3.5M
CPB icon
1378
Campbell Soup
CPB
$6.51B
-6,011
Closed -$240K
CPRT icon
1379
Copart
CPRT
$25.9B
-10,119
Closed -$573K
CRI icon
1380
Carter's
CRI
$1.43B
-9,392
Closed -$384K
CRL icon
1381
Charles River Laboratories
CRL
$10.9B
-5,163
Closed -$777K
CRM icon
1382
Salesforce
CRM
$134B
-20,003
Closed -$5.37M
CRUS icon
1383
Cirrus Logic
CRUS
$6.74B
-150,000
Closed -$14.9M
CRVS icon
1384
Corvus Pharmaceuticals
CRVS
$1.1B
-29,858
Closed -$94.9K
CSGP icon
1385
PUT
CoStar Group
CSGP
$11.3B
-48,486
Closed -$3.84M
CVS icon
1386
CALL
CVS Health
CVS
$137B
-6,200
Closed -$420K
CYTK icon
1387
Cytokinetics
CYTK
$11B
-20,000
Closed -$804K
CZR icon
1388
Caesars Entertainment
CZR
$6.1B
-57,589
Closed -$1.44M
DAL icon
1389
CALL
Delta Air Lines
DAL
$55.9B
-100,000
Closed -$4.36M
DAL icon
1390
PUT
Delta Air Lines
DAL
$55.9B
-100,000
Closed -$4.36M
DCTH icon
1391
Delcath Systems
DCTH
$422M
-14,179
Closed -$180K
DECK icon
1392
Deckers Outdoor
DECK
$13.3B
-19,500
Closed -$2.18M
DESP
1393
DELISTED
Despegar.com
DESP
-223,696
Closed -$4.2M
DFS
1394
DELISTED
Discover Financial Services
DFS
-100,807
Closed -$17.2M
DHR icon
1395
Danaher
DHR
$135B
-52,378
Closed -$10.7M
DINO icon
1396
HF Sinclair
DINO
$15.9B
-16,219
Closed -$533K
DKNG icon
1397
DraftKings
DKNG
$11.4B
-10,187
Closed -$365K
DLTR icon
1398
CALL
Dollar Tree
DLTR
$23.1B
-73,100
Closed -$5.49M
DMAC icon
1399
DiaMedica Therapeutics
DMAC
$363M
-15,167
Closed -$57.5K
DOV icon
1400
Dover
DOV
$27.2B
-1,648
Closed -$290K

Similar funds

LMR Partners's Q2 2025 Portfolio in Review

As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
  • LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
  • LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
  • LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
  • LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
  • LMR Partners opened 418 new positions and closed 391 in Q2 2025.
  • LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.